JPRN-UMIN000026535尚未招募未知
Open-label, uncontrolled, non-randamized study of healthy subjects on quality control (reproducibility) of nerve conduction study - Research on quality control of nerve conduction study
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •No exclusion criteria
研究者
相似试验
进行中（未招募）
1 期
An Open Study of the Efficacy, Durability, and Safety of a new drug in Patients with Bladder Cancer (ATLAS)EUCTR2020-003541-11-EEroGen Pharma Ltd.632
进行中（未招募）
1 期
An Open Study of the Efficacy, Durability, and Safety of a new drug in Patients with Bladder Cancer (ATLAS)on-Muscle Invasive Bladder CancerMedDRA version: 20.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2020-003541-11-PLroGen Pharma Ltd.632
进行中（未招募）
1 期
An Open Study of the Efficacy, Durability, and Safety of a new drug in Patients with Bladder Cancer (ATLAS)EUCTR2020-003541-11-BGroGen Pharma Ltd.632
进行中（未招募）
1 期
An Open Study of the Efficacy, Durability, and Safety of a new drug in Patients with Bladder Cancer (ATLAS)on-Muscle Invasive Bladder CancerMedDRA version: 20.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2020-003541-11-LVroGen Pharma Ltd.632
已完成
不适用
Open-label, non-randomized study investigating the excretion balance, Pharmacokinetics, and metabolism of a single oral dose of [14c]-labeled ro6868847 in healthy male participantsDiabetic retinopathy10012653DiabetesNL-OMON51247F. Hoffmann-La Roche Ltd10